FINWIRES · TerminalLIVE
FINWIRES

$ARGX

14 stories mentioning ARGX

Every FINWIRES story that references ARGX, newest first.

Asia Markets

European Equities Traded in US as ADRs Rise in Thursday Trading

European equities traded in the US as American depositary receipts rose late Thursday morning with the S&P Europe Select ADR Index climbing 1.7% to 1,874.97.From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and semiconductor company Sequans Communications (SQNS), which rose 2.7% and 2.6%, respectively. They were followed by biotech firm BioNTech (BNTX) and telecommunications company Nokia (NOK), which were up 2.5% and 1.6%, respectively.The decliners from continental Europe were led by software firm SAP (SAP) and internet ad firm Criteo (CRTO), which dropped 4.1% and 0.9%, respectively. They were followed by biotech firm Evaxion (EVAX) and consumer goods company Unilever (UL), which were off 0.4% and 0.1%, respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which climbed 8.8% and 4%, respectively. They were followed by lender HSBC (HSBC) and biotech firm Autolus Therapeutics (AUTL), which advanced 2.8% and 2.7%, respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and software company Endava (DAVA), which fell 4.6% and 1.1%, respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and NuCana (NCNA), which lost 0.9% and 0.8%, respectively.

$ARGX$AUTL$BDRX$BNTX$CRTO$DAVA$EVAX$HSBC$MREO$NCNA$NOK$SAP$SLN$SQNS$TRIB$UL
Research

William O'Neil Initiates argenx at Buy

argenx SE ADR (ARGX) has an average rating of buy and mean price target of $1,058.49, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ARGX
Asia Markets

European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week

European equities traded in the US as American depositary receipts were tracking lower late Friday morning, falling 0.85% to 1,882.19 on the S&P Europe Select ADR Index, which is up 0.9% for the week so far.From continental Europe, the gainers were led by internet ad firm Criteo (CRTO) and consumer goods company Unilever (UL), which rose 2.1% and 2% respectively. They were followed by biopharmaceutical companies argenx (ARGX) and Cellectis (CLLS), which were up 1.8% and 0.7% respectively.The decliners from continental Europe were led by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which dropped 8.3% and 7.2% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and telecommunications company Ericsson (ERIC), which lost 5.4% and 2.9% respectively.The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and alcoholic beverage company Diageo (DEO), which advanced 4.5% and 2.4% respectively. They were followed by tobacco company British American Tobacco (BTI) and educational publisher Pearson (PSO), which increased 2.1% and 1.9% respectively.The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and mining company BHP Group (BHP), which lost 6.3% and 5.3% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which dropped 3% and 2.2% respectively.

$AKTX$ARGX$AUTL$BHP$BTI$CLLS$CRTO$DBVT$DEO$ERIC$NOK$PSO$SLN$SQNS$TRIB$UL
Asia Markets

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were declining late Wednesday morning, falling 0.58% to 1,880.17 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and petroleum refiner Equinor (EQNR), which rose 2.1% and 1.3%, respectively. They were followed by oil and gas company Eni (E) and biopharmaceutical company argenx (ARGX), which were up 1% and 0.5%, respectively.The decliners from continental Europe were led by internet ad firm Criteo (CRTO) and biopharmaceutical company Cellectis (CLLS), which fell 7% and 4.7%, respectively. They were followed by biotech firm Evaxion (EVAX) and software company SAP (SAP), which were down 4.6% and 4.5%, respectively.The gainers from the UK were led by Mereo BioPharma Group (MREO), which advanced 5.6%. It was followed by pharmaceutical company Silence Therapeutics (SLN) and medical device maker Smith & Nephew (SNN), which increased 4.8% and 2%, respectively.The decliners from the UK and Ireland were led by communications company WPP (WPP) and software company Endava (DAVA), which dropped 4.5% and 4.4%, respectively. They were followed by lender Barclays (BCS) and biotech firm Autolus Therapeutics (AUTL), which lost 2.4% and 1.7%, respectively.

$ARGX$AUTL$BCS$CLLS$CRTO$DAVA$E$EQNR$EVAX$MREO$NCNA$NOK$SAP$SLN$SNN$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.7% to 1,889.9 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications companies Ericsson (ERIC) and Nokia (NOK), which rose 2.9% and 2.4% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and lender Banco Santander (SAN), which were up 1.3% each.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and software firm SAP (SAP), which fell 6.4% and 4.3% respectively. They were followed by biopharmaceutical company argenx (ARGX) and semiconductor company Sequans Communications (SQNS), which lost 3.9% and 3.6% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and lender Barclays (BCS), which advanced 10.4% and 3.2% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and hospitality company InterContinental Hotels Group (IHG), which increased 2.5% and 2.4% respectively.The decliners from the UK and Ireland were led by software firm Endava (DAVA) and biopharmaceutical company Bicycle Therapeutics (BCYC), which dropped 4.9% and 3.8% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and communications company WPP (WPP), which were down 3.7% and 3.2% respectively.

$AKTX$ARGX$BCS$BCYC$BDRX$BUD$DAVA$DBVT$ERIC$IHG$MREO$NOK$SAN$SAP$SQNS$WPP
Wire

Argenx Appears Confident of Rebound in Q2, RBC Says

Argenx (ARGX) appears confident of a rebound in Q2 with robust Vyvgart momentum amid high demand and record new patient starts in Q1, RBC Capital Markets said in a Wednesday research report.Vyvgart does not require serotype confirmation before use, potentially eliminating a rate-limiting step in prescribing the medication, but formulary access could take six months, indicating that revenue growth will take time to accelerate, analysts wrote.Regarding the pipeline, myositis is on track for Q3 and remains the biggest upcoming potential catalyst for the stock, according to the note.Argenx isn't actively pursuing merger transactions imminently, given the preference for biology bets at early, R&D stage that adds synergistic value to the company's pipeline, RBC stated.The brokerage said it reiterated its outperform rating on the stock and price target of $890 per share.Price: $824.04, Change: $+15.61, Percent Change: +1.93%

$ARGX
Asia Markets

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

European equities traded in the US as American depositary receipts were tracking lower late Wednesday morning, declining 0.48% to 1,880.02 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet advertising firm Criteo (CRTO) and biopharmaceutical company argenx (ARGX), which rose 5% and 2.8% respectively. They were followed by consumer goods company Unilever (UL) and biotech firm BioNTech (BNTX), which were up 2.1% and 1.9% respectively.The decliners from continental Europe were led by telecommunications companies Ericsson (ERIC) and Nokia (NOK), which dropped 4.1% and 3.4% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and oil and gas company Eni (E), which lost 3.3% and 3% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics (AUTL) and software company Endava (DAVA), which advanced 3.7% and 3.4% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and alcoholic beverage company Diageo (DEO), which increased 3% and 2.7% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and oil and gas company BP (BP), which fell 13% and 3.2% respectively. They were followed by utilities company National Grid (NGG) and oil and gas company Shell (SHEL), which were down 2.2% and 2.1% respectively.

$AKTX$ARGX$AUTL$BNTX$BP$CRTO$DAVA$DEO$E$ERIC$NGG$NOK$SHEL$SLN$SQNS$UL
Asia Markets

European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.3% to 1,824.16 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by software firm SAP (SAP) and internet advertising company Criteo (CRTO), which advanced 5.3% and 3.6% respectively. They were followed by biopharmaceutical company argenx (ARGX) and petroleum refiner Equinor (EQNR), which rose 2.1% and 1.3% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and telecommunications company Nokia (NOK), which dropped 3.5% and 2.7% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and medical device maker EDAP TMS (EDAP), which were off 2.6% and 1.6% respectively.The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics (AKTX) and NuCana (NCNA), which were up 4.9% and 3.5% respectively. They were followed bybiopharmaceutical company Biodexa Pharmaceuticals (BDRX) and medical device company Smith & Nephew (SNN), which were up 3.1% and 2.6% respectively.The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL), which fell 8%, followed by mining company BHP Group (BHP) and pharmaceutical company Silence Therapeutics (SLN), which lost 3% and 0.6% respectively.

$AKTX$ARGX$AUTL$BDRX$BHP$CLLS$CRTO$EDAP$EQNR$NCNA$NOK$SAP$SLN$SNN$SQNS
Asia Markets

European Equities Traded in the US as American Depositary Receipts Start Week Lower

European equities traded in the US as American depositary receipts kicked off the week lower late Monday morning, falling 0.70% to 1,803.50 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company argenx (ARGX), which climbed 8.1% and 1.9% respectively. They were followed by petroleum refiner Equinor (EQNR) and biopharmaceutical company Grifols (GRFS), which advanced 1.8% and 1.5% respectively.The decliners from continental Europe were led by pharmaceutical company Sanofi (SNY) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which dropped 5.5% and 4.2% respectively. They were followed by medical device maker EDAP TMS (EDAP) and biopharmaceutical company Cellectis (CLLS), which lost 3.3% and 1% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and biotech firm Autolus Therapeutics (AUTL), which rose 9.2% and 2.8% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Amarin (AMRN), which were up 2.3% and 2.2% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and cruise line operator Carnival (CUK), which fell 2.2% and 1.6% respectively. They were followed by pharmaceutical company GSK (GSK) and biotech firm Trinity Biotech (TRIB), which were down 1.2% and 0.4% respectively.

$AKTX$AMRN$ARGX$AUTL$BBVA$BDRX$CLLS$CUK$EDAP$EQNR$GRFS$GSK$NCNA$SNY$SQNS$TRIB
Asia Markets

European Equities Traded in US as ADRs Ease in Thursday Trading

European equities traded in the US as American depositary receipts eased late Thursday morning with the S&P Europe Select ADR Index dropping 0.1% to 1,801.52.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and pharmaceutical company Sanofi (SNY), which rose 6.4% and 2.5%, respectively. They were followed by biopharmaceutical company argenx (ARGX) and medical device maker EDAP TMS (EDAP), which were up 0.7% and 0.6%, respectively.The decliners from continental Europe were led by software firm SAP (SAP) and internet advertising company Criteo (CRTO), which fell 5% and 3.5%, respectively. They were followed by internet browser company Opera (OPRA) and 3D printer company Materialise (MTLS), which were down 3.2% and 3.1%, respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and hospitality company InterContinental Hotels Group (IHG), which advanced 4.8% and 2.4%, respectively. They were followed by biopharmaceutical company Amarin (AMRN) and telecommunications operator Vodafone Group (VOD), which increased 2% and 1.6%, respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which lost 6.4% and 6.2%, respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Akari Therapeutics (AKTX), which dropped 6.1% and 2.6%, respectively.

$AKTX$AMRN$ARGX$BDRX$CRTO$DAVA$EDAP$IHG$MTLS$NOK$OPRA$SAP$SLN$SNY$TRIB$VOD
Asia Markets

European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were falling sharply late Tuesday morning, dropping 1.15% to 1,812.72 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and internet browser company Opera (OPRA), which rose 2.7% and 1.7% respectively. They were followed by 3D printer company Materialise (MTLS) and medical device maker EDAP TMS (EDAP), which were up 1.2% each.The decliners from continental Europe were led by biopharmaceutical company argenx (ARGX) and pharmaceutical company Novo Nordisk (NVO), which fell 3% and 2.8% respectively. They were followed by biotech firm Evaxion (EVAX) and pharmaceutical company Ascendis Pharma (ASND), which were down 2.7% each.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and software firm Endava (DAVA), which advanced 6.4% and 2.7% respectively. They were followed by education company Pearson (PSO) and pharmaceutical company Silence Therapeutics (SLN), which increased 1.2% and 0.9% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and NuCana (NCNA), which dropped 8.7% and 3.2% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and cruise line operator Carnival (CUK), which lost 2.3% and 2.2% respectively.

$AKTX$ARGX$ASND$BDRX$CUK$DAVA$EDAP$EQNR$EVAX$MREO$MTLS$NCNA$NVO$OPRA$PSO$SLN
Wire

Argenx's Vyvgart Seen Gaining More Patients in Coming Months, Wedbush Says

Argenx's (ARGX) Vyvgart remains the fastest-growing treatment for chronic inflammatory demyelinating polyneuropathy, or CIDP, with its patient share expected to rise to 23% from 18%, Wedbush Securities said Thursday in a report.Survey results by Wedbush support Argenx's Vyvgart revenue forecasts of $1.3 billion for Q1 and $5.8 billion for 2026, including $2 billion from CIDP and $3.8 billion from generalized myasthenia gravis, according to the report.Wedbush said it sees additional upside from potential near-term approvals in seronegative and ocular myasthenia gravis, which could broaden the number of patients eligible for the drug.Argenx offers an attractive opportunity given its growth outlook and current valuation, the report said.Wedbush maintained its outperform rating on Argenx stock with a $1,000 price target.Q1 results are due May 7.Price: $828.68, Change: $-12.19, Percent Change: -1.45%

$ARGX
Asia Markets

European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading

European equities traded in the US as American depositary receipts were trending lower late Thursday morning, declining 0.42% to 1,823.55 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and internet browser company Opera (OPRA), which advanced 4.4% and 3.7%, respectively. They were followed by petroleum refiner Equinor (EQNR) and software firm SAP (SAP), which increased 3.6% and 3.1%, respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and biotech firm Evaxion (EVAX), which dropped 3% and 1.6%, respectively. They were followed by biopharmaceutical companies DBV Technologies (DBVT) and argenx (ARGX), which fell 1.3% and 1.1%, respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and communications company WPP (WPP), which rose 4.3% and 2.8%, respectively. They were followed by educational publisher Pearson (PSO) and oil and gas company BP (BP), which were up 2.4% and 2.1%, respectively.The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biopharmaceutical company Bicycle Therapeutics (BCYC), which lost 4.6% and 2.8%, respectively. They were followed by biopharmaceutical company NuCana (NCNA) and pharmaceutical company GSK (GSK), which were down 1.7% and 0.9%, respectively.

$ARGX$BCYC$BP$CLLS$CUK$DBVT$EQNR$EVAX$GSK$NCNA$OPRA$PSO$SAP$SQNS$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were heading lower late Wednesday morning, declining 0.54% to 1,835.78 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biopharmaceutical firm Grifols (GRFS), which advanced 3% and 2.6%, respectively. They were followed by software company SAP (SAP) and biopharmaceutical company argenx (ARGX), which increased 2.5% each.The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and telecommunications company Nokia (NOK), which dropped 4.2% and 1.6%, respectively. They were followed by telecommunications company Ericsson (ERIC) and petroleum refiner Equinor (EQNR), which lost 1.5% and 1.2%, respectively.The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and software company Endava (DAVA), which rose 3.2% each. They were followed by biopharmaceutical companies Amarin (AMRN) and NuCana (NCNA), which were up 3% and 2.3% respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Mereo BioPharma Group (MREO), which fell 2.9% and 2.6% respectively. They were followed by pharmaceutical company AstraZeneca (AZN) and utilities company National Grid (NGG), which were down 1.3% and 1.2% respectively.

$AMRN$ARGX$AZN$DAVCA$EDAP$EQNR$ERIC$GRFS$MREO$NCNA$NGG$NOK$NTZ$SAP$TRIB$VDRZ